Hanazawa; Takeshi

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hanazawa; Takeshi.The latest application filed is for "imidazopyridine compounds".

Company Profile

0.6.8

Hanazawa; Takeshi - Tokyo JP
Hanazawa; Takeshi - Aichi-ken JP
Hanazawa; Takeshi - Chita-gun JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Imidazopyridine compounds Grant 9,447,090 - Koga , et al. September 20, 2	2016-09-20
Imidazopyridine compounds Grant 9,278,968 - Kurosaki , et al. March 8, 2	2016-03-08
Imidazopyridine Compounds App 20150232464 - Kurosaki; Toshio ; et al.	2015-08-20
Imidazopyridine Compounds App 20140088080 - KOGA; Yuji ; et al.	2014-03-27
Diacylethylenediamine Compound App 20120046292 - Kawano; Tomoaki ; et al.	2012-02-23
Substituted Aryloxoethyl Cyclopropanecarboxamide Compounds As Vr1 Receptor Antagonists App 20110152326 - Hanazawa; Takeshi ; et al.	2011-06-23
Substituted sulfonylaminoarylmethyl cyclopropanecarboxamide as VR1 receptor antagonists Grant 7,915,448 - Hanazawa , et al. March 29, 2	2011-03-29
Chromane substituted benzimidazole derivatives Grant 7,723,321 - Hanazawa , et al. May 25, 2	2010-05-25
Substituted Sulfonylaminoarylmethyl Cyclopropanecarboxamide As Vr1 Receptor Antagonists App 20100035880 - HANAZAWA; TAKESHI ; et al.	2010-02-11
Substituted sulfonylaminoarylmethyl cyclopropanecarboxamide as VR1 receptor antagonists Grant 7,622,589 - Hanazawa , et al. November 24, 2	2009-11-24
Substituted N-sulfonylaminophenylethyl-2-phenoxyacetamide compounds as VR1 receptor antagonists Grant 7,566,739 - Hanazawa , et al. July 28, 2	2009-07-28
Chromane Substituted Benzimidazole Derivatives App 20070142448 - Hanazawa; Takeshi ; et al.	2007-06-21
Substituted sulfonylaminoarylmethyl cyclopropanecarboxamide as VR1 receptor antagonists App 20060211741 - Hanazawa; Takeshi ; et al.	2006-09-21
Substituted N-sulfonylaminophenylethyl-2-phenoxyacetamide compounds as VR1 receptor antagonists App 20060205980 - Hanazawa; Takeshi ; et al.	2006-09-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.